These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4113442)

  • 1. B.C.N.U. (1,3-bis (2-chloroethyl) -1-nitrosourea) in the treatment of advanced Hodgkin's disease.
    Cipriani D; Strinchini A
    Lancet; 1972 Jun; 1(7764):1345. PubMed ID: 4113442
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU.
    Young RC; DeVita VT; Serpick AA; Canellos GP
    N Engl J Med; 1971 Aug; 285(9):475-9. PubMed ID: 5558887
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of resistant Hodgkin's disease.
    Lancet; 1971 Oct; 2(7729):860. PubMed ID: 4106882
    [No Abstract]   [Full Text] [Related]  

  • 4. BCNU (1,3,bis(B-chloroethyl)-1-nitrosourea. Effects on advanced Hodgkin's disease and other neoplasia.
    Lessner HE
    Cancer; 1968 Aug; 22(2):451-6. PubMed ID: 4873194
    [No Abstract]   [Full Text] [Related]  

  • 5. The response of human lymphoma cells in vitro to bleomycin and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Drewinko B; Novak JK; Barranco SC
    Cancer Res; 1972 Jun; 32(6):1206-8. PubMed ID: 4113143
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors.
    Kinne DW; Humphrey EW
    Cancer Chemother Rep; 1972 Feb; 56(1):53-9. PubMed ID: 5030809
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Hodgkin's disease and other cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Marsh JC; DeConti RC; Hubbard SP
    Cancer Chemother Rep; 1971 Dec; 55(5):599-606. PubMed ID: 4334161
    [No Abstract]   [Full Text] [Related]  

  • 8. 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer.
    van Eden EB; Falkson HC; Falkson G
    Cancer Chemother Rep; 1970 Oct; 54(5):347-59. PubMed ID: 5514624
    [No Abstract]   [Full Text] [Related]  

  • 9. Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Res; 1972 Jun; 32(6):1280-2. PubMed ID: 5030827
    [No Abstract]   [Full Text] [Related]  

  • 10. A phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC79037) in the palliative management of advanced gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Res; 1972 Jun; 32(6):1278-9. PubMed ID: 4113144
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the management of patients with advanced breast cancer.
    Ahmann DL; Hahn RG; Bisel HF
    Cancer Chemother Rep; 1972 Feb; 56(1):93-4. PubMed ID: 5030810
    [No Abstract]   [Full Text] [Related]  

  • 12. 1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors.
    Wilson CB; Boldrey EB; Enot KJ
    Cancer Chemother Rep; 1970 Aug; 54(4):273-81. PubMed ID: 4334089
    [No Abstract]   [Full Text] [Related]  

  • 13. BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report.
    Walker MD; Hurwitz BS
    Cancer Chemother Rep; 1970 Aug; 54(4):263-71. PubMed ID: 4946011
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the chemotherapy of experimental brain tumors: evaluation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, vincristine, and 5-fluorouracil.
    Shapiro WR
    J Natl Cancer Inst; 1971 Feb; 46(2):359-68. PubMed ID: 4256014
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy of Hodgkin's disease.
    Weinrach RS
    Ariz Med; 1971 Apr; 28(4):281-4. PubMed ID: 4995470
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of mycosis fungoides with topical nitrosourea compounds.
    Zackheim HS
    Arch Dermatol; 1972 Aug; 106(2):177-82. PubMed ID: 5048217
    [No Abstract]   [Full Text] [Related]  

  • 17. 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and methotrexate (NSC-740) as combination therapy for advanced mouse leukemia L1210.
    Venditti JM; Kline I; Tyrer DD; Goldin A
    Cancer Chemother Rep; 1965 Oct; 48():35-9. PubMed ID: 5834736
    [No Abstract]   [Full Text] [Related]  

  • 18. Structure-activity relationships: nitrosoureas.
    Johnston TP
    Cancer Chemother Rep 3; 1972 May; 3(1):50-1. PubMed ID: 5065660
    [No Abstract]   [Full Text] [Related]  

  • 19. Results with CCNU in resistant Hodgkin's and non-Hodgkin's lymphoma.
    Stolinsky DC; Solomon J; Weiner JM; Bateman JR
    Oncology; 1976; 33(5-6):271-3. PubMed ID: 800240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of malignant brain tumors with nitrosoureas.
    Hansen HH; Muggia FM
    Cancer Chemother Rep; 1971 Apr; 55(2):99-100. PubMed ID: 4330275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.